Section 1 Short title
This Act may be cited as the “Inpatient Opioid Safety Act of 2021”.
Inpatient Opioid Safety Act of 2021
A BILL
To amend titles XVIII and XIX of the Social Security Act to provide for the improvement of patient safety and to reduce the incidence of injury and death from opioid-induced respiratory depression under the Medicare and Medicaid programs.
Sec. 2 Preventing opioid-induced respiratory depression and deaths under the Medicare and Medicaid programs through required monitoring
in subparagraph (X), by striking “and” at the end;
in subparagraph (Y)(ii)(V), by striking the period and inserting “; and”; and
by inserting after subparagraph (Y) the following new subparagraph:
“(Z) in the case of a hospital or critical access hospital and with respect to an individual who is furnished, on or after July 1, 2022, any opioid (regardless of route of administration) while an inpatient of such hospital or critical access hospital, to furnish to such individual, during the period beginning at the time such opioid is furnished and ending 12 hours later (or, if earlier, the time such individual is discharged), continuous physiologic electronic monitoring through a monitor that—
“(i) measures the adequacy of the respiration of such individual to detect opioid-induced respiratory depression needing intervention;
“(ii) can be configured to manage excess false alarms; and
“(iii) records and transmits information on blood oxygenation or ventilation of such individual,”
in paragraph (86), by striking “and” at the end;
in paragraph (87), by striking the period and inserting “; and”; and
by inserting after paragraph (87) the following new paragraph:
“(88) provide that no hospital is eligible to receive payments under such plan unless such hospital furnishes continuous physiologic electronic monitoring in accordance with the provisions of section 1866(a)(1)(Z).”